Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s stock price dropped 2.5% on Wednesday . The company traded as low as $9.10 and last traded at $9.29. Approximately 503,473 shares were traded during trading, a decline of 9% from the average daily volume of 551,962 shares. The stock had previously closed at $9.53.
Cybin Trading Down 2.5 %
The firm has a market capitalization of $1.38 billion and a price-to-earnings ratio of -38.71. The stock’s 50 day moving average price is $9.53 and its two-hundred day moving average price is $7.60.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
- Five stocks we like better than Cybin
- Where to Find Earnings Call Transcripts
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- How to Buy Cheap Stocks Step by Step
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How to Plot Fibonacci Price Inflection Levels
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
